We additionally identified significant differences in important biologic factors, including AST and ALT, that have been shown to be elevated in nonalcoholic fatty liver disease (NAFLD), a disorder with a bi-directional association with MetS and individual risk factors [25,26]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.